论文部分内容阅读
目的:探究生化检验在小儿支原体肺炎合并肝损伤、心肌损伤的诊断中所具有的临床价值。方法:择取2014年11月到2016年11月期间于郑州儿童医院治疗小儿支原体肺炎合并肝损伤、心肌损伤的40例患儿,设其为研究组;择取同期于郑州儿童医院接受体检的40例健康儿童,设其为对照组。全部给予生化检验,对比两组受检对象在生化检验结果上的不同。结果:研究组的C反应蛋白、血沉、各项心肌功能指标与肝功能指标的测定结果均高于对照组,统计学有差异(P<0.05)。结论:小儿支原体肺炎合并肝损伤、心肌损伤患者和健康儿童在生化检验指标上有很大差异,临床可以借助若干生化指标的检验来实现疾病的准确测定。
Objective: To investigate the clinical value of biochemical tests in the diagnosis of children with mycoplasmal pneumonia complicated with liver injury and myocardial injury. Methods: From November 2014 to November 2016, 40 children with mycoplasma pneumonia and liver injury and myocardial injury in Children’s Hospital of Zhengzhou were enrolled in this study group. The patients were selected as research group. At the same time, 40 healthy children, set it as the control group. All given biochemical tests, comparing the two groups of subjects biochemical test results on the different. Results: C-reactive protein, erythrocyte sedimentation rate, myocardial function indexes and liver function indexes in the study group were all higher than those in the control group (P <0.05). Conclusion: Mycoplasma pneumonia in children with liver injury, myocardial injury and healthy children in biochemical test indicators are very different, clinically with the help of a number of biochemical tests to achieve the accurate determination of the disease.